Health Care & Life Sciences » Pharmaceuticals | Shenzhen Salubris Pharmaceuticals Co. Ltd.

Shenzhen Salubris Pharmaceuticals Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,292
2,840
3,427
3,769
4,076
4,571
Cost of Goods Sold (COGS) incl. D&A
570
773
923
974
837
1,057
Gross Income
1,722
2,067
2,504
2,794
3,240
3,515
SG&A Expense
770
893
1,047
1,186
1,612
1,873
EBIT
949
1,170
1,452
1,628
1,628
1,649
Unusual Expense
-
-
6
-
-
1
Non Operating Income/Expense
11
1
1
6
45
8
Interest Expense
-
-
-
-
1
7
Pretax Income
977
1,215
1,493
1,652
1,717
1,711
Income Tax
143
174
222
260
278
252
Equity in Affiliates
-
3
2
1
2
5
Consolidated Net Income
833
1,043
1,270
1,390
1,437
1,455
Net Income
830
1,042
1,266
1,396
1,452
1,458
Net Income After Extraordinaries
830
1,042
1,266
1,396
1,452
1,458
Net Income Available to Common
830
1,042
1,266
1,396
1,452
1,458
EPS (Basic)
0.79
0.99
1.21
1.33
1.39
1.39
Basic Shares Outstanding
1,046
1,046
1,046
1,046
1,046
1,046
EPS (Diluted)
0.79
1.00
1.21
1.33
1.39
1.39
Diluted Shares Outstanding
1,046
1,046
1,046
1,046
1,046
1,046
EBITDA
1,005
1,236
1,534
1,744
1,765
1,830
Other Operating Expense
3
4
5
20
-
6
Non-Operating Interest Income
18
35
21
31
45
34
Minority Interest Expense
3
1
4
6
15
4

About Shenzhen Salubris Pharmaceuticals Co.

View Profile
Address
37/F, Chegongmiao Lujing Plaza Bldg
Shenzhen Guangdong 518040
China
Employees -
Website http://www.salubris.cn
Updated 07/08/2019
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and biomedical products. It offers cardiovascular drugs and antibiotics, and active pharmaceutical ingredient products. The company was founded on November 3, 1998 and is headquartered in Shenzhen, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.